Tue, January 4, 2022

Elemer Piros Upgraded (UBX) to Strong Buy and Held Target at $40 on, Jan 4th, 2022

Elemer Piros of Roth Capital, Upgraded "Unity Biotechnology, Inc." (UBX) to Strong Buy and Held Target at $40 on, Jan 4th, 2022.

Elemer has made no other calls on UBX in the last 4 months.



There is 1 other peer that has a rating on UBX. Out of the 1 peers that are also analyzing UBX, 0 agree with Elemer's Rating of Hold.



This is the rating of the analyst that currently disagrees with Elemer


  • Salim Syed of "Mizuho" Upgraded from Hold to Strong Buy and Increased Target to $70 on, Wednesday, November 10th, 2021